+72%

est. 2Y upside i

AerospaceSeries B

Kela is a secure, open platform enabling rapid and seamless integration of commercial and military systems in service of Western defense.

Rank

#1173

Sector

Aerospace and Defense

Est. Liquidity

~5Y

Data Quality

Data: Low

Kela is a high-conviction defense-tech bet with genuinely strong strategic investors and a defensible mission, but the 2-year horizon is almost certainly too short for liquidity — defense procurement rarely closes that fast for a company founded in 2024.

Last updated: May 5, 2026

Bull (28%)+220%

Kela wins multiple large NATO and US DoD contracts, with In-Q-Tel backing accelerating classified program access; the Starling drone partnership and Pelanor AI acquisition compound into a defensible multi-domain platform, pushing valuation toward $1.2–1.5B by 2027–2028. A strategic acquisition by a Tier-1 prime contractor or a pre-IPO secondary round at elevated multiples creates early liquidity above grant price.

Base (47%)+55%

Kela secures a handful of mid-size Western defense contracts by 2027, growing headcount past 300 and establishing referenceable deployments; valuation reaches roughly $600–650M on the back of a Series C, but no liquidity event materializes within the 2-year window. Employee common stock appreciates modestly, offset by a meaningful dilution round required to fund continued R&D and the Pelanor integration.

Bear (25%)-60%

Government procurement cycles stretch beyond projections and the Israeli HQ creates friction for accessing classified US programs, stalling the revenue ramp; a down/flat Series C is raised at $200–250M to extend runway, severely diluting early common-stock holders relative to the $100M preference stack. The 2-year horizon ends with equity worth roughly 40 cents on the grant-price dollar for employees.

Est. time to liquidity~5.0 years

Preference Stack Risk

high

Funding Intensity

27%

Total funding of $100M sits against an estimated post-Series B valuation of $300–450M (undisclosed); liquidation preferences likely represent 22–33% of exit proceeds, squarely in the high-risk band before common stock holders see a dollar.

Dilution Risk

high

A company founded in 2024 at Series B with no disclosed revenue will almost certainly require at least one more institutional round (Series C) and possibly a Series D before reaching liquidity, likely diluting early common grants by 20–40% on top of existing dilution.

Secondary Liquidity

none

No secondary market activity is evident for a company this young and early-stage in the defense tech sector; employees should assume equity is fully illiquid until an M&A exit or IPO, neither of which is foreseeable within 2 years.

Questions to Ask at the Interview

Strategic questions based on Kela's data — designed to show you've done your homework.

  • 1

    Kela's headquarters are in Tel Aviv — what is the concrete plan for accessing classified US DoD and IC programs beyond In-Q-Tel introductions, and are there plans for a US-domiciled subsidiary with cleared personnel?

  • 2

    What does a typical first contract look like — fixed-fee milestone, IDIQ, or OTA — and what is the average contract value and duration you are targeting in the first two years?

  • 3

    What is the current post-money valuation and the strike price or FMV at which new equity grants are being issued, and how many additional funding rounds do you anticipate before a liquidity event?

Community

Valuation Sentiment

Our model estimates +72% upside. What do you think?

Anonymous. Do not share material non-public information.


Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.